Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Omaxe Limited is a prominent real estate developer in India, primarily engaged in residential and commercial projects across key metropolitan areas such as Delhi NCR, Punjab, and Uttar Pradesh. The company differentiates itself through its diverse portfolio, which includes integrated townships, shopping malls, and office spaces, while facing challenges from negative margins and declining revenue growth.
Omaxe generates revenue primarily through the sale of residential units and commercial properties, along with ongoing income from leasing commercial spaces. The company's competitive advantage lies in its established brand presence and strategic land acquisitions in high-demand regions, although it currently struggles with negative gross margins due to high operational costs.
Changes in housing demand in metropolitan areas like Delhi NCR
Government policies affecting real estate development and housing finance
Interest rate fluctuations impacting mortgage affordability
Trends in commercial real estate occupancy rates
Regulatory changes affecting land acquisition and construction permits
Economic downturns leading to reduced consumer spending on real estate
Increasing competition from other established developers in key markets
Emergence of new entrants leveraging technology for cost-effective construction
High operational losses impacting liquidity and cash flow
Negative equity position due to sustained losses
high - The real estate sector is closely tied to GDP growth and consumer spending, as housing demand typically rises in a robust economic environment.
Rising interest rates increase borrowing costs for homebuyers, which can dampen demand for residential properties and negatively impact Omaxe's sales.
minimal - The company is less dependent on credit markets for financing, given its high current ratio and negative debt/equity ratio.
value - Investors may be drawn to Omaxe due to its low price-to-sales ratio, despite current operational challenges.
high - The stock has shown significant price fluctuations, evidenced by its recent 25.1% return over three months.
